x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DPP-001054
| Product Overview | |
|---|---|
| Species | Human |
| Expression System | Wheat germ |
| Format | Liquid |
| Purity | ≥ 99% by HPLC |
| Nature | Recombinant |
| Target Information | |
|---|---|
| Gene Name | AHSG |
| UniProt No. | P02765 |
| Gene ID | 197 |
| Alternative Names | 59 kDa bone sialic acid containing protein; A2HS; Aa2 066; AHS; Ahsg; Alpha 2 HS glycoprotein; Alpha 2 HS glycoprotein chain A; Alpha 2 HS glycoprotein chain B; Alpha 2 Z globulin; Alpha 2HS glycoprotein; Alpha-2-HS-glycoprotein chain B; Alpha-2-Z-globulin; alpha2 Heremans Schmid glycoprotein; Asialofetuin; Ba alpha 2 glycoprotein; Ba-alpha-2-glycoprotein; BSP; Countertrypin; FETUA; FETUA_HUMAN; Fetuin A; Fetuin, mouse, homolog of; Fetuin-A; FetuinA; Glycoprotein PP63; HSGA; pp63 |
| Function | Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions. |
| Cellular Localization | Secreted. |
| Protein Length | Full length protein |
| Sequence | APHGPGLIYRQPNCDDPETEEAALVAIDYINQNLPWGYKHTLNQIDEVKV WPQQPSGELFEIEIDTLETTCHVLDPTPVARCSVRQLKEHAVEGDCDFQL LKLDGKFSVVYAKCDSSPDSAEDVRKVCQDCPLLAPLNDTRVVHAAKAAL AAFNAQNNGSNFQLEEISRAQLVPLPPSTYVEFTVSGTDCVAKEATEAAK CNLLAEKQYGFCKATLSEKLGGAEVAVTCTVFQTQPVTSQPQPEGANEAV PTPVVDPDAPPSPPLGAPGLPPAGSPPDSHVLLAAPPGHQLHRAHYDLRH TFMGVVSLGSPSGEVSHPRKTRTVVQPSVGAAAGPVVPPCPGRIRHFKV,Belongs to the fetuin family. Contains 2 cystatin fetuin-A-type domains. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped on dry ice. |
| Storage | Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
